secwatch.observer — SEC 8-K summary
======================================

Issuer:     Terns Pharmaceuticals, Inc. (TERN)
CIK:        0001831363
Form:       8-K
Filed at:   2024-07-29T23:59:59+00:00
Accession:  0000950170-24-087284
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Terns appoints new Chief Legal Officer; CFO and General Counsel to depart in planned transitions
--------------------------------------------------------------------------------

- Elona Kogan appointed Chief Legal Officer effective July 29; previously CLO at Seer, Inc.
- CFO Mark Vignola to leave by Feb 1, 2025 or upon successor; receives $475k severance plus $500k retention bonus.
- General Counsel Bryan Yoon steps down, becomes COO/Special Counsel until Sep 3, 2024; receives $490,700 severance.
- Search for new CFO underway; Vignola and Yoon remain in transition roles.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831363/000095017024087284/0000950170-24-087284-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831363/000095017024087284/tern-20240723.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-087284

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer